Aclasta solutie perfuzabila 5 mg/100 ml モルドバ - ルーマニア語 - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

aclasta solutie perfuzabila 5 mg/100 ml

novartis pharma ag - acidum zoledronicum - solutie perfuzabila - 5 mg/100 ml

Livogiva 欧州連合 - ルーマニア語 - EMA (European Medicines Agency)

livogiva

theramex ireland limited - teriparatidul - osteoporoza - homeostazia de calciu - livogiva is indicated in adults. tratamentul osteoporozei la femeile aflate în postmenopauză și la bărbații cu risc crescut de fractură. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. tratamentul osteoporozei asociate cu sustinut sistemice terapia cu glucocorticoizi la femei și bărbați cu risc crescut de fractură.

Chondroguard 100 mg/ml soluţie injectabilă モルドバ - ルーマニア語 - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

chondroguard 100 mg/ml soluţie injectabilă

farmfirma sotex saÎ - chondroitini sulfas - soluţie injectabilă - 100 mg/ml

Sondelbay 欧州連合 - ルーマニア語 - EMA (European Medicines Agency)

sondelbay

accord healthcare s.l.u. - teriparatidul - osteoporoza - homeostazia de calciu - sondelbay is indicated in adults. tratamentul osteoporozei la femeile aflate în postmenopauză și la bărbații cu risc crescut de fractură. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. tratamentul osteoporozei asociate cu sustinut sistemice terapia cu glucocorticoizi la femei și bărbați cu risc crescut de fractură.

Kauliv 欧州連合 - ルーマニア語 - EMA (European Medicines Agency)

kauliv

strides pharma (cyprus) limited - teriparatidul - osteoporosis; osteoporosis, postmenopausal - homeostazia de calciu - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

prolia solutie injectabila 60 mg/ml モルドバ - ルーマニア語 - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

prolia solutie injectabila 60 mg/ml

amgen europe b.v. - solutie injectabila - 60 mg/ml

prolia solutie injectabila in seringa preumpluta 60 mg/ml モルドバ - ルーマニア語 - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

prolia solutie injectabila in seringa preumpluta 60 mg/ml

amgen europe b.v. - solutie injectabila in seringa preumpluta - 60 mg/ml

prolia™ 60 mg 60 mg/ml soluţie injectabilă în seringă preumplută モルドバ - ルーマニア語 - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

prolia™ 60 mg 60 mg/ml soluţie injectabilă în seringă preumplută

amgen europe b.v. - denosumabum - soluţie injectabilă în seringă preumplută - 60 mg/ml

Teriparatide Sun 欧州連合 - ルーマニア語 - EMA (European Medicines Agency)

teriparatide sun

sun pharmaceutical industries europe b.v. - teriparatidul - osteoporosis; osteoporosis, postmenopausal - homeostazia de calciu - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

ACID IBANDRONIC FRESENIUS KABI 3 mg ルーマニア - ルーマニア語 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

acid ibandronic fresenius kabi 3 mg

fresenius kabi romania sr.l. - acidum ibandronicum - sol. inj. in seringa preumpluta - 3mg - med. ce influenteaza in structura osoasa si mineralizare bifosfonati